Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Symptoms, complications and management of long COVID: a review

OL Aiyegbusi, SE Hughes, G Turner… - Journal of the Royal …, 2021 - journals.sagepub.com
Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3
million deaths. While the majority of infected individuals recover, a significant proportion …

[HTML][HTML] First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

CR Simpson, T Shi, E Vasileiou, SV Katikireddi… - Nature medicine, 2021 - nature.com
Reports of ChAdOx1 vaccine–associated thrombocytopenia and vascular adverse events
have led to some countries restricting its use. Using a national prospective cohort, we …

[HTML][HTML] Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis

EM Mansory, S Srigunapalan, A Lazo-Langner - TH Open, 2021 - thieme-connect.com
Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

[HTML][HTML] COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

J Leentjens, TF Van Haaps, PF Wessels… - The Lancet …, 2021 - thelancet.com
COVID-19 is associated with a high incidence of thrombotic complications, which can be
explained by the complex and unique interplay between coronaviruses and endothelial …

[HTML][HTML] The COVID complex: a review of platelet activation and immune complexes in COVID-19

SD Jevtic, I Nazy - Frontiers in Immunology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a highly prothrombotic viral infection that primarily
manifests as an acute respiratory syndrome. However, critically ill COVID-19 patients will …

[HTML][HTML] COVID-19 infection and its impact on case fatality in patients with pulmonary embolism

L Hobohm, I Sagoschen, S Barco… - European …, 2023 - Eur Respiratory Soc
Background Although a high prevalence of pulmonary embolism (PE) has been reported in
association with coronavirus disease 2019 (COVID-19) in critically ill patients, nationwide …

Insights on the mechanisms of action of ozone in the medical therapy against COVID-19

S Chirumbolo, L Valdenassi, V Simonetti… - International …, 2021 - Elsevier
An increasing amount of reports in the literature is showing that medical ozone (O 3) is used,
with encouraging results, in treating COVID-19 patients, optimizing pain and symptoms …

[HTML][HTML] From ancient leech to direct thrombin inhibitors and beyond: New from old

MR Montinari, S Minelli - Biomedicine & pharmacotherapy, 2022 - Elsevier
Medicinal leeches have been used in health care since before written history, with widely
varying popularity over the centuries. Nowadays, medicinal leech therapy is mainly used in …